click below
click below
Normal Size Small Size show me how
review
module 9
| QUESTION | ANSWER | ANSWER | ANSWER | ANSWER | ANSWERS | ANSWER | ANSWER |
|---|---|---|---|---|---|---|---|
| EACH ________ IS RESPONSIBLE FOR CREATION THEIR OWN __________ _____ FOR ____ ____ PACKAGES | STATE, EXPIRATION DATES, UNIT DOSE | ||||||
| ____ ____ IS USED FOR A ________ SETTING NOT FOR _______ HOME OR ____ ____ ____ FACILITIES, THEY USE THE _____ ____ METHOD | UNIT DOSE, HOSPITAL, NURSING, LONG TERM CARE, BINGO CARD | ||||||
| WHEN A ___________ HAS A RECALL ON A MEDICATION YOU MUST KEEP ______ OF WHO TOOK THE DRUG AND HOW MANY OF THE DRUG YOU HAVE LEFT | MANUFACTURE, RECORD | ||||||
| THINGS LIKE ________, ___, ___________, AND __, CAN RUIN THE STABILITY OF THE DRUG | LIGHTING, AIR, TEMPERATURE, PH | ||||||
| REMEMBER THAT ALL ________ TRAYS AND THE UNIT DOSE PACKAGING MACHINE MUST BE CLEANED WITH ________ AFTER EVERY USE | COUNTING, ALCOHOL | ||||||
| 4 BASIC FUNCTIONS A DRUG PACKAG MUST FULLFIL: | IDENTIFY THE CONTENTS WITH THE PACKAGE | PROTECT THE CONTENTS FROM ENVIRONMENTAL EFFECTS | PROTECTS THE CONTENTS FROM DETERIATION | THE CONTENTS MUST BE USED QUICKLY EASILY AND SAFETLY | |||
| LIST THE 7 LABELING REQUIREMENTS FOR UNIT DOSE PACKAGED DRUGS: | NON PROPRIETARY NAME (GENERIC) | (PROPRIETARY NAME )(BRAND) | DOSAGE FORM (ER, LA) | STRENGTH OF DOSE AND TOTAL CONTENTS DELIVERED | SPECIAL NOTES (DO NOT CHEW | EXPIRATION DATE | CONTROL NUMBER (LOT NUMBER |
| LIST THE SPECIFIC CONSIDERATIONS FOR ORAL SOLIDS FOR BLISTER PACKAGES: | HAVE AN OPAQUE AND NON REFLECTIVE BACKING FOR PRINTING | HAVE A BLISTER OF A TRANSPARENT MATERIAL | BE EASILY PEELABLE | IF CONTROLLED SUBSTANCE BE NUMBERED SEQUENTIALLY | |||
| AND POUCH PACKAGING: | HAVE ONE SIDE OPAQUE AND NON REFLECTIVE FOR PRINTING | BE EASILY DELIVERABLE | TEAR FROM ANY POINT OR MULTIPLE LOCATIONS | IF CONTROLLED SUBSTANCE BE NUMBERED SEQUENTIALLY | |||
| IN THE ASHP READING LIST THE CONTENTS THAT MUST BE ON AN ORAL LIQUID LABEL: | DELIVERS __MG,G,MCG, IN __ML | FOR ORAL USE ONLY | |||||
| THE PERSON PACKAGING THE UNIT DOSE MEDICATION CANNONT ______ THIER OWN WOR | VERIFY | ||||||
| WHAT ARE THE GUIDELINES THAT MUST BE USED WHEN SELECTING A CONTAINER TO REPACKAGE: | MATERIAL MUST PROTECT THE CONTENTS FROM THE ELEMENTS | MATERIAL MUST BE OF HIGH QUALITY | MATERIAL MUST NOT INTERACT WITH THE MEDICATION | THE MATERIAL SHOULD BE EASY OPEN | THE MATERIAL MUST BE EASILY INSPECTED | USP DEFINITION OF CONTAINERS | |
| LIST THE USP GUIDELINES FOR THE CLASSIFICATION OF PACKAGE TYPES: | CLASS A: LEAST AMOUNT OF MOISTURE PERMEATION | CLASS B- MORE MOISTURE PERMEATION | CLASS C- MORE MOISTURE PERMEATION THAN CLASS B | CLASS D- HIGHEST AMOUNT OF MOISTURE PERMEATION | |||
| IDENTIFY THE ROLE OF THE PHARMACY TECHNICIAN IN TQI (TOTAL QUALITY IMPROVEMENT) | DATA COLLECTION | DEVELOPING IN-PROCESS CONTROLS | NEW EMPLOYEE ORIENTATION | DRUG UTILIZATION | REPORTING ADR | MEDICATION INCIDENT REPORTING | DEVELOPING AND/OR REVISING POLICIES AND PROCEDURES |
| LIST ALL THE STEPS THAT MUST BE COMPLEATED AT THE END OF A PACKAGING RUN | ALL UNUSED DRUG STOCK AND FINISHED PACKAGES SHOULD BE REMOVED FROM THE PACKAGING AREA | THE PACKAGING MACHINE MUST BE EMPTIED, CLEANED, AND INSPECTED BEFORE THE NEXT PACKAGING OPERATION | UNUSED LABELS SHOULD BE STORED IN A TEMPERATURE AND HUMIDITY CONTROLLED ENVIRONMENT | UNUSED LABELS SHOULD BE REMOVED FROM THE PACKAGING AREA |